Search

"tumor heterogeneity"

CAR T Cell Adds Scorpion Venom to Tackle Tumor Heterogeneity
CAR T Cell Adds Scorpion Venom to Tackle Tumor Heterogeneity
Amy Schleunes | Mar 24, 2020
A newly engineered CAR T cell that incorporates a peptide isolated from the venom of the deathstalker scorpion has broad brain tumor–binding capabilities that will be investigated in an upcoming clinical trial.
High Tumor Heterogeneity Confirmed
Sabrina Richards | Mar 9, 2012
One biopsy may not provide enough information about the array of mutations in cancer to devise treatments based on a tumor’s genetic profile.
Immunotherapy Combo Reduces Solid Tumors in Mice
Immunotherapy Combo Reduces Solid Tumors in Mice
Amanda Heidt | Sep 9, 2020
When tumor cells are infected with an oncolytic virus carrying a modified CD19 gene, they become targets for CAR T cells engineered to recognize this molecular marker.
Revealing the Complexities of Cancer with Single-cell RNA Analysis
Revealing the Complexities of Cancer with Single-cell RNA Analysis
The Scientist Creative Services Team | Aug 19, 2020
Download this eBook to learn how single-cell analysis identifies subpopulations of tumor cells!
Cancer Researchers Use Evolution to Target Drug Resistance
Cancer Researchers Use Evolution to Target Drug Resistance
Catherine Offord | Apr 1, 2020
New therapeutic approaches in oncology aim to manipulate or block cancer’s adaptation to treatment.
Infographic: Researchers Take Aim at Cancer Evolution
Infographic: Researchers Take Aim at Cancer Evolution
Catherine Offord | Apr 1, 2020
Strategies to trick, manipulate, and direct the evolution of tumors
Cancer Cells Fuse with Immune Cells in Human Patients
Cancer Cells Fuse with Immune Cells in Human Patients
Anna Azvolinsky | Sep 13, 2018
The hybrid cells promote tumor heterogeneity and possible metastasis, a new study in mice and humans shows.
Harnessing the Most Powerful Cells Crucial to Accelerating Curative Medicines
Harnessing the Most Powerful Cells Crucial to Accelerating Curative Medicines
IsoPlexis | Nov 12, 2020
The IsoSpark, a personalized proteomics system for any laboratory, makes unique functional proteomics accessible to every lab, providing an integrated and flexible solution for accelerating curative medicines. 
Genetic and Spatial Heterogeneity in Human Papillomavirus-Associated Oropharyngeal Cancer
Genetic and Spatial Heterogeneity in Human Papillomavirus-Associated Oropharyngeal Cancer
The Scientist Creative Services Team | Aug 20, 2020
Joseph Powell will discuss how heterogeneous subpopulations of HPV+ head and neck cancer cells drive unique disease states, cell-cell interactions, and microenvironment dynamics, and have implications for cancer behavior, metastasis, and response to treatment.   
<em>The Scientist</em> on the Pulse, April 23
The Scientist on the Pulse, April 23
Kerry Grens | Apr 23, 2015
Hot topics in cancer research from the annual meeting of the American Association for Cancer Research

Refine your Search

Search Again